http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005532277-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
| filingDate | 2003-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005532277-A |
| titleOfInvention | A method for obtaining dibenzylbutyrolactonic lignans; a method for obtaining synthetic derivatives from lignans having chemopreventive and therapeutic activity of anti-chagas. |
| abstract | A method for obtaining dibenzylbutyrolactonic lignans; a method for obtaining synthetic derivatives from lignans having chemopreventive and therapeutic activities of anti-chagas. The present invention relates to a method for obtaining lignans, and in particular to a method for obtaining cobebin and methylpulviatrid from the leaves of santoxiram narrandillo or piper cubebba. Also, semi-synthetic derivatives of cubine, in particular dibenzylbutyrolactonic lignans such as hinokine, o-acetyl cubine, o-methyl cubine, 6,6′-dinitro hinoki nin and o-dimethylethylamine cubine, and The method for obtaining other derivatives obtained in the same way as obtaining methylprubiatolide derivatives is recognized by gentian violet and other compounds conventionally used for blood treatment and prevention of Chagas disease. Used to produce drugs that give at least 5 times higher activity than is possible. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013515014-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010536718-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020142993-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7197908-B2 |
| priorityDate | 2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.